Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trialPascal Vranckx, Ángel Cequier, Eugène McFadden et al.|The Lancet|2018Cited by 793
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding RiskMarco Valgimigli, Pieter C. Smits, Enrico Frigoli et al.|New England Journal of Medicine|2021Cited by 571
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled TrialPieter C. Smits, Enrico Frigoli, Jan G.P. Tijssen et al.|Circulation|2021Cited by 77
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) StudyEnrico Frigoli, Marco Valgimigli, Pieter C. Smits et al.|American Heart Journal|2018Cited by 62